Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
4.860
+0.250 (5.42%)
At close: Dec 8, 2025, 4:00 PM EST
4.930
+0.070 (1.44%)
After-hours: Dec 8, 2025, 7:19 PM EST
Annexon Market Cap
Annexon has a market cap or net worth of $724.41 million as of December 8, 2025. Its market cap has increased by 24.47% in one year.
Market Cap
724.41M
Enterprise Value
564.86M
1-Year Change
24.47%
Ranking
Category
Stock Price
$4.86
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $724.41M, an increase of 13.28%. That is a compound annual growth rate of 2.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 687.15M | 25.66% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | 955.09M | 49.35% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.94B |
| Johnson & Johnson | 488.48B |
| AbbVie | 398.49B |
| UnitedHealth Group | 293.80B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 244.65B |
| Thermo Fisher Scientific | 215.28B |